-
1
-
-
34249950342
-
Herpes simplex viruses
-
Lippincott Williams & Wilkins, Philadelphia, PA.
-
Roizman B, Knipe DM. 2006. Herpes simplex viruses, p 2502-2601. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
-
(2006)
In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed.
, pp. 2502-2601
-
-
Roizman, B.1
Knipe, D.M.2
-
2
-
-
39149089061
-
Varicella-zoster virus replication,athogenesis, and management
-
Lippincott Williams & Wilkins, Philadelphia, PA.
-
Cohen J, Straus S, Arvin A. 2006. Varicella-zoster virus replication, pathogenesis, and management, p 2774-2818. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
-
(2006)
In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed.
, pp. 2774-2818
-
-
Cohen, J.1
Straus, S.2
Arvin, A.3
-
3
-
-
34548158284
-
Cytomegaloviruses
-
Lippincott Williams & Wilkins, Philadelphia, PA.
-
Mocarski E, Shenk T, Pass R. 2006. Cytomegaloviruses, p 2702-2772. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
-
(2006)
In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed.
, pp. 2702-2772
-
-
Mocarski, E.1
Shenk, T.2
Pass, R.3
-
4
-
-
57849153584
-
Human herpesviruses 6 and 7
-
Lippincott Williams & Wilkins, Philadelphia, PA.
-
Yamanashi K, Mori Y, Pellett P. 2006. Human herpesviruses 6 and 7, p 2819-2845. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
-
(2006)
In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed.
, pp. 2819-2845
-
-
Yamanashi, K.1
Mori, Y.2
Pellett, P.3
-
5
-
-
35348962397
-
Kaposi's sarcoma-associated herpesvirus
-
Lippincott Williams & Wilkins, Philadelphia, PA.
-
Ganem D. 2006. Kaposi's sarcoma-associated herpesvirus, p 2847-2888. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
-
(2006)
In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed.
, pp. 2847-2888
-
-
Ganem, D.1
-
6
-
-
34249064632
-
Epstein-Barr virus
-
Lippincott Williams & Wilkins, Philadelphia, PA.
-
Rickinson A, Kieff E. 2006. Epstein-Barr virus, p 2655-2700. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
-
(2006)
In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed.
, pp. 2655-2700
-
-
Rickinson, A.1
Kieff, E.2
-
7
-
-
77950805340
-
Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant
-
Meng Q, Hagemeier SR, Kuny CV, Kalejta RF, Kenney SC. 2010. Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant. J. Virol. 84:4524-4533.
-
(2010)
J. Virol.
, vol.84
, pp. 4524-4533
-
-
Meng, Q.1
Hagemeier, S.R.2
Kuny, C.V.3
Kalejta, R.F.4
Kenney, S.C.5
-
8
-
-
0027323128
-
Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells
-
Purves FC, Ogle WO, Roizman B. 1993. Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. U. S. A. 90:6701-6705.
-
(1993)
Proc. Natl. Acad. Sci. U. S. A.
, vol.90
, pp. 6701-6705
-
-
Purves, F.C.1
Ogle, W.O.2
Roizman, B.3
-
9
-
-
20444377669
-
Varicella-zoster virus open reading frame 47 (ORF47) protein is critical for virus replication in dendritic cells and for spread to other cells
-
Hu H, Cohen JI. 2005. Varicella-zoster virus open reading frame 47 (ORF47) protein is critical for virus replication in dendritic cells and for spread to other cells. Virology 337:304-311.
-
(2005)
Virology
, vol.337
, pp. 304-311
-
-
Hu, H.1
Cohen, J.I.2
-
10
-
-
0032578408
-
The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse
-
Moffat JF, Zerboni L, Sommer MH, Heineman TC, Cohen JI, Kaneshima H, Arvin AM. 1998. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl. Acad. Sci. U. S. A. 95:11969-11974.
-
(1998)
Proc. Natl. Acad. Sci. U. S. A.
, vol.95
, pp. 11969-11974
-
-
Moffat, J.F.1
Zerboni, L.2
Sommer, M.H.3
Heineman, T.C.4
Cohen, J.I.5
Kaneshima, H.6
Arvin, A.M.7
-
11
-
-
34248339596
-
Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus
-
Gershburg E, Raffa S, Torrisi MR, Pagano JS. 2007. Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus. J. Virol. 81:5407-5412.
-
(2007)
J. Virol.
, vol.81
, pp. 5407-5412
-
-
Gershburg, E.1
Raffa, S.2
Torrisi, M.R.3
Pagano, J.S.4
-
12
-
-
0033033631
-
A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency
-
Prichard MN, Gao N, Jairath S, Mulamba G, Krosky P, Coen DM, Parker BO, Pari GS. 1999. A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J. Virol. 73:5663-5670.
-
(1999)
J. Virol.
, vol.73
, pp. 5663-5670
-
-
Prichard, M.N.1
Gao, N.2
Jairath, S.3
Mulamba, G.4
Krosky, P.5
Coen, D.M.6
Parker, B.O.7
Pari, G.S.8
-
13
-
-
0028009537
-
Characterization of the putative protein kinases specified by varicella-zoster virus genes 47 and 66
-
Stevenson D, Colman KL, Davison AJ. 1994. Characterization of the putative protein kinases specified by varicella-zoster virus genes 47 and 66. J. Gen. Virol. 75(Part 2):317-326.
-
(1994)
J. Gen. Virol.
, vol.75
, Issue.PART 2
, pp. 317-326
-
-
Stevenson, D.1
Colman, K.L.2
Davison, A.J.3
-
14
-
-
0033052041
-
ICP22 and the UL13 protein kinase are both required for herpes simplex virusinduced modification of the large subunit of RNA polymerase II
-
Long MC, Leong V, Schaffer PA, Spencer CA, Rice SA. 1999. ICP22 and the UL13 protein kinase are both required for herpes simplex virusinduced modification of the large subunit of RNA polymerase II. J. Virol. 73:5593-5604.
-
(1999)
J. Virol.
, vol.73
, pp. 5593-5604
-
-
Long, M.C.1
Leong, V.2
Schaffer, P.A.3
Spencer, C.A.4
Rice, S.A.5
-
15
-
-
0038082392
-
The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase
-
Krosky PM, Baek M-C, Jahng WJ, Barrera I, Harvey RJ, Biron KK, Coen DM, Sethna PB. 2003. The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J. Virol. 77:7720-7727.
-
(2003)
J. Virol.
, vol.77
, pp. 7720-7727
-
-
Krosky, P.M.1
Baek, M.-C.2
Jahng, W.J.3
Barrera, I.4
Harvey, R.J.5
Biron, K.K.6
Coen, D.M.7
Sethna, P.B.8
-
16
-
-
0037708793
-
The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44
-
Marschall M, Freitag M, Suchy P, Romaker D, Kupfer R, Hanke M, Stamminger T. 2003. The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 311:60-71.
-
(2003)
Virology
, vol.311
, pp. 60-71
-
-
Marschall, M.1
Freitag, M.2
Suchy, P.3
Romaker, D.4
Kupfer, R.5
Hanke, M.6
Stamminger, T.7
-
17
-
-
0035852743
-
Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation
-
Wolf DG, Courcelle CT, Prichard MN, Mocarski ES. 2001. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc. Natl. Acad. Sci. U. S. A. 98: 1895-1900.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A.
, vol.98
, pp. 1895-1900
-
-
Wolf, D.G.1
Courcelle, C.T.2
Prichard, M.N.3
Mocarski, E.S.4
-
18
-
-
0037225808
-
The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress
-
Krosky PM, Baek M-C, Coen DM. 2003. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 77:905-914.
-
(2003)
J. Virol.
, vol.77
, pp. 905-914
-
-
Krosky, P.M.1
Baek, M.-C.2
Coen, D.M.3
-
19
-
-
59249092261
-
Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress
-
doi:10.1371/journal .ppat.1000275.
-
Hamirally S, Kamil JP, Ndassa-Colday YM, Lin AJ, Jahng WJ, Baek M-C, Noton S, Silva LA, Simpson-Holley M, Knipe DM, Golan DE, Marto JA, Coen DM. 2009. Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog. 5:e1000275. doi:10.1371/journal .ppat.1000275.
-
(2009)
PLoS Pathog.
, vol.5
-
-
Hamirally, S.1
Kamil, J.P.2
Ndassa-Colday, Y.M.3
Lin, A.J.4
Jahng, W.J.5
Baek, M.-C.6
Noton, S.7
Silva, L.A.8
Simpson-Holley, M.9
Knipe, D.M.10
Golan, D.E.11
Marto, J.A.12
Coen, D.M.13
-
20
-
-
80054896036
-
Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication
-
Li R, Zhu J, Xie Z, Liao G, Liu J, Chen M-R, Hu S, Woodard C, Lin J, Taverna SD, Desai P, Ambinder RF, Hayward GS, Qian J, Zhu H, Hayward SD. 2011. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe 10:390-400.
-
(2011)
Cell Host Microbe
, vol.10
, pp. 390-400
-
-
Li, R.1
Zhu, J.2
Xie, Z.3
Liao, G.4
Liu, J.5
Chen, M.-R.6
Hu, S.7
Woodard, C.8
Lin, J.9
Taverna, S.D.10
Desai, P.11
Ambinder, R.F.12
Hayward, G.S.13
Qian, J.14
Zhu, H.15
Hayward, S.D.16
-
21
-
-
84861302962
-
SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function
-
Li R, Wang L, Liao G, Guzzo CM, Matunis MJ, Zhu H, Hayward SD. 2012. SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. J. Virol. 86:5412-5421.
-
(2012)
J. Virol.
, vol.86
, pp. 5412-5421
-
-
Li, R.1
Wang, L.2
Liao, G.3
Guzzo, C.M.4
Matunis, M.J.5
Zhu, H.6
Hayward, S.D.7
-
22
-
-
45549092198
-
Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase
-
Yang P-W, Chang S-S, Tsai C-H, Chao Y-H, Chen M-R. 2008. Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase. J. Gen. Virol. 89:884-895.
-
(2008)
J. Gen. Virol.
, vol.89
, pp. 884-895
-
-
Yang, P.-W.1
Chang, S.-S.2
Tsai, C.-H.3
Chao, Y.-H.4
Chen, M.-R.5
-
23
-
-
0034011617
-
A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro
-
Chen MR, Chang SJ, Huang H, Chen JY. 2000. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J. Virol. 74:3093-3104.
-
(2000)
J. Virol.
, vol.74
, pp. 3093-3104
-
-
Chen, M.R.1
Chang, S.J.2
Huang, H.3
Chen, J.Y.4
-
24
-
-
0036143222
-
Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBVSun et al
-
on August 30, 2013 by Elsevier Bibliographic Databasesencoded protein kinase and effects of the L-riboside benzimidazole 1263W94. J. Virol.
-
Gershburg E, Pagano JS. 2002. Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBVSun et al. 10136 jvi.asm.org Journal of Virology Downloaded from http://jvi.asm.org/ on August 30, 2013 by Elsevier Bibliographic Databasesencoded protein kinase and effects of the L-riboside benzimidazole 1263W94. J. Virol. 76:998-1003.
-
(2002)
10136 jvi.asm.org Journal of Virology Downloaded from
, vol.76
, pp. 998-1003
-
-
Gershburg, E.1
Pagano, J.S.2
-
25
-
-
65349113014
-
Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4
-
Zhu J, Liao G, Shan L, Zhang J, Chen M-R, Hayward GS, Hayward SD, Desai P, Zhu H. 2009. Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4. J. Virol. 83:5219-5231.
-
(2009)
J. Virol.
, vol.83
, pp. 5219-5231
-
-
Zhu, J.1
Liao, G.2
Shan, L.3
Zhang, J.4
Chen, M.-R.5
Hayward, G.S.6
Hayward, S.D.7
Desai, P.8
Zhu, H.9
-
26
-
-
17444372050
-
Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter
-
Yue W, Gershburg E, Pagano JS. 2005. Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter. J. Virol. 79:5880-5885.
-
(2005)
J. Virol.
, vol.79
, pp. 5880-5885
-
-
Yue, W.1
Gershburg, E.2
Pagano, J.S.3
-
27
-
-
0348013196
-
Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function
-
Kato K, Yokoyama A, Tohya Y, Akashi H, Nishiyama Y, Kawaguchi Y. 2003. Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function. J. Gen. Virol. 84:3381-3392.
-
(2003)
J. Gen. Virol.
, vol.84
, pp. 3381-3392
-
-
Kato, K.1
Yokoyama, A.2
Tohya, Y.3
Akashi, H.4
Nishiyama, Y.5
Kawaguchi, Y.6
-
28
-
-
33646737238
-
Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1
-
Asai R, Kato A, Kato K, Kanamori-Koyama M, Sugimoto K, Sairenji T, Nishiyama Y, Kawaguchi Y. 2006. Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1. J. Virol. 80:5125-5134.
-
(2006)
J. Virol.
, vol.80
, pp. 5125-5134
-
-
Asai, R.1
Kato, A.2
Kato, K.3
Kanamori-Koyama, M.4
Sugimoto, K.5
Sairenji, T.6
Nishiyama, Y.7
Kawaguchi, Y.8
-
29
-
-
67650511701
-
Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication
-
Iwahori S, Murata T, Kudoh A, Sato Y, Nakayama S, Isomura H, Kanda T, Tsurumi T. 2009. Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication. J. Biol. Chem. 284: 18923-18931.
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 18923-18931
-
-
Iwahori, S.1
Murata, T.2
Kudoh, A.3
Sato, Y.4
Nakayama, S.5
Isomura, H.6
Kanda, T.7
Tsurumi, T.8
-
30
-
-
78149328426
-
Cyclindependent kinase-like function is shared by the beta-and gamma-subset of the conserved herpesvirus protein kinases
-
doi:10.1371/journal.ppat.1001092.
-
Kuny CV, Chinchilla K, Culbertson MR, Kalejta RF. 2010. Cyclindependent kinase-like function is shared by the beta-and gamma-subset of the conserved herpesvirus protein kinases. PLoS Pathog. 6:e1001092. doi:10.1371/journal.ppat.1001092.
-
(2010)
PLoS Pathog.
, vol.6
-
-
Kuny, C.V.1
Chinchilla, K.2
Culbertson, M.R.3
Kalejta, R.F.4
-
31
-
-
56449106108
-
Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production
-
Lee C-P, Huang Y-H, Lin S-F, Chang Y, Chang Y-H, Takada K, Chen M-R. 2008. Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J. Virol. 82:11913-11926.
-
(2008)
J. Virol.
, vol.82
, pp. 11913-11926
-
-
Lee, C.-P.1
Huang, Y.-H.2
Lin, S.-F.3
Chang, Y.4
Chang, Y.-H.5
Takada, K.6
Chen, M.-R.7
-
32
-
-
59649113242
-
Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway
-
Wang J-T, Doong S-L, Teng S-C, Lee C-P, Tsai C-H, Chen M-R. 2009. Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J. Virol. 83:1856-1869.
-
(2009)
J. Virol.
, vol.83
, pp. 1856-1869
-
-
Wang, J.-T.1
Doong, S.-L.2
Teng, S.-C.3
Lee, C.-P.4
Tsai, C.-H.5
Chen, M.-R.6
-
33
-
-
70350289948
-
The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production
-
Feederle R, Mehl-Lautscham AM, Bannert H, Delecluse H-J. 2009. The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production. J. Virol. 83:10877-10891.
-
(2009)
J. Virol.
, vol.83
, pp. 10877-10891
-
-
Feederle, R.1
Mehl-Lautscham, A.M.2
Bannert, H.3
Delecluse, H.-J.4
-
34
-
-
44049107548
-
Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function
-
Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta RF. 2008. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320:797-799.
-
(2008)
Science
, vol.320
, pp. 797-799
-
-
Hume, A.J.1
Finkel, J.S.2
Kamil, J.P.3
Coen, D.M.4
Culbertson, M.R.5
Kalejta, R.F.6
-
36
-
-
79953035666
-
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
-
Marty FM, Ljungman P, Papanicolaou GA, Winston DJ, Chemaly RF, Strasfeld L, Young J-AH, Rodriguez T, Maertens J, Schmitt M, Einsele H, Ferrant A, Lipton JH, Villano SA, Chen H, Boeckh M. 2011. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect. Dis. 11:284-292.
-
(2011)
Lancet Infect. Dis.
, vol.11
, pp. 284-292
-
-
Marty, F.M.1
Ljungman, P.2
Papanicolaou, G.A.3
Winston, D.J.4
Chemaly, R.F.5
Strasfeld, L.6
Young, J.-A.H.7
Rodriguez, T.8
Maertens, J.9
Schmitt, M.10
Einsele, H.11
Ferrant, A.12
Lipton, J.H.13
Villano, S.A.14
Chen, H.15
Boeckh, M.16
-
37
-
-
0002391736
-
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1
-
Cheng YC, Huang ES, Lin JC, Mar EC, Pagano JS, Dutschman GE, Grill SP. 1983. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc. Natl. Acad. Sci. U. S. A. 80:2767-2770.
-
(1983)
Proc. Natl. Acad. Sci. U. S. A.
, vol.80
, pp. 2767-2770
-
-
Cheng, Y.C.1
Huang, E.S.2
Lin, J.C.3
Mar, E.C.4
Pagano, J.S.5
Dutschman, G.E.6
Grill, S.P.7
-
39
-
-
0023633942
-
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
-
Lin JC, DeClercq E, Pagano JS. 1987. Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication. Antimicrob. Agents Chemother. 31:1431-1433.
-
(1987)
Antimicrob. Agents Chemother.
, vol.31
, pp. 1431-1433
-
-
Lin, J.C.1
DeClercq, E.2
Pagano, J.S.3
-
40
-
-
0024041143
-
Antiviral activity and mechanism of action of ganciclovir
-
Matthews T, Boehme R. 1988. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10(Suppl 3):S490-S494.
-
(1988)
Rev. Infect. Dis.
, vol.10
, Issue.SUPPL 3
-
-
Matthews, T.1
Boehme, R.2
-
41
-
-
0026664424
-
Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir
-
Littler E, Stuart AD, Chee MS. 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358:160-162.
-
(1992)
Nature
, vol.358
, pp. 160-162
-
-
Littler, E.1
Stuart, A.D.2
Chee, M.S.3
-
42
-
-
0027110881
-
A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells
-
Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. 1992. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 359:85.
-
(1992)
Nature
, vol.359
, pp. 85
-
-
Sullivan, V.1
Talarico, C.L.2
Stanat, S.C.3
Davis, M.4
Coen, D.M.5
Biron, K.K.6
-
43
-
-
0032838505
-
Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein
-
Talarico CL, Burnette TC, Miller WH, Smith SL, Davis MG, Stanat SC, Ng TI, He Z, Coen DM, Roizman B, Biron KK. 1999. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein. Antimicrob. Agents Chemother. 43:1941-1946.
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, pp. 1941-1946
-
-
Talarico, C.L.1
Burnette, T.C.2
Miller, W.H.3
Smith, S.L.4
Davis, M.G.5
Stanat, S.C.6
Ng, T.I.7
He, Z.8
Coen, D.M.9
Roizman, B.10
Biron, K.K.11
-
44
-
-
4444256678
-
Antivirals and antiviral strategies
-
De Clercq E. 2004. Antivirals and antiviral strategies. Nat. Rev. Microbiol. 2:704-720.
-
(2004)
Nat. Rev. Microbiol.
, vol.2
, pp. 704-720
-
-
De Clercq, E.1
-
45
-
-
23844456404
-
Epstein-Barr virus infections: prospects for treatment
-
Gershburg E, Pagano JS. 2005. Epstein-Barr virus infections: prospects for treatment. J. Antimicrob. Chemother. 56:277-281.
-
(2005)
J. Antimicrob. Chemother.
, vol.56
, pp. 277-281
-
-
Gershburg, E.1
Pagano, J.S.2
-
46
-
-
77950850768
-
The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production
-
Meng Q, Hagemeier SR, Fingeroth JD, Gershburg E, Pagano JS, Kenney SC. 2010. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production. J. Virol. 84:4534-4542.
-
(2010)
J. Virol.
, vol.84
, pp. 4534-4542
-
-
Meng, Q.1
Hagemeier, S.R.2
Fingeroth, J.D.3
Gershburg, E.4
Pagano, J.S.5
Kenney, S.C.6
-
47
-
-
84861088675
-
Heat shock proteins in cancer: targeting the "chaperones
-
Nahleh Z, Tfayli A, Najm A, El Sayed A, Nahle Z. 2012. Heat shock proteins in cancer: targeting the "chaperones." Future Med. Chem. 4:927-935.
-
(2012)
Future Med. Chem.
, vol.4
, pp. 927-935
-
-
Nahleh, Z.1
Tfayli, A.2
Najm, A.3
El Sayed, A.4
Nahle, Z.5
-
49
-
-
84865695733
-
Quantitative analysis of Hsp90-client interactions reveals principles of substrate recognition
-
Taipale M, Krykbaeva I, Koeva M, Kayatekin C, Westover KD, Karras GI, Lindquist S. 2012. Quantitative analysis of Hsp90-client interactions reveals principles of substrate recognition. Cell 150:987-1001.
-
(2012)
Cell
, vol.150
, pp. 987-1001
-
-
Taipale, M.1
Krykbaeva, I.2
Koeva, M.3
Kayatekin, C.4
Westover, K.D.5
Karras, G.I.6
Lindquist, S.7
-
50
-
-
84875519144
-
Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions
-
Hong DS, Banerji U, Tavana B, George GC, Aaron J, Kurzrock R. 2013. Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions. Cancer Treat. Rev. 39:375-387.
-
(2013)
Cancer Treat. Rev.
, vol.39
, pp. 375-387
-
-
Hong, D.S.1
Banerji, U.2
Tavana, B.3
George, G.C.4
Aaron, J.5
Kurzrock, R.6
-
51
-
-
0030863995
-
The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation
-
Grenert JP, Sullivan WP, Fadden P, Haystead TA, Clark J, Mimnaugh E, Krutzsch H, Ochel HJ, Schulte TW, Sausville E, Neckers LM, Toft DO. 1997. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J. Biol. Chem. 272:23843-23850.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 23843-23850
-
-
Grenert, J.P.1
Sullivan, W.P.2
Fadden, P.3
Haystead, T.A.4
Clark, J.5
Mimnaugh, E.6
Krutzsch, H.7
Ochel, H.J.8
Schulte, T.W.9
Sausville, E.10
Neckers, L.M.11
Toft, D.O.12
-
52
-
-
0031444238
-
Identification and structural characterization of the ATP/ADPbinding site in the Hsp90 molecular chaperone
-
Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, Pearl LH. 1997. Identification and structural characterization of the ATP/ADPbinding site in the Hsp90 molecular chaperone. Cell 90:65-75.
-
(1997)
Cell
, vol.90
, pp. 65-75
-
-
Prodromou, C.1
Roe, S.M.2
O'Brien, R.3
Ladbury, J.E.4
Piper, P.W.5
Pearl, L.H.6
-
53
-
-
0141484615
-
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
-
Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ. 2003. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425:407-410.
-
(2003)
Nature
, vol.425
, pp. 407-410
-
-
Kamal, A.1
Thao, L.2
Sensintaffar, J.3
Zhang, L.4
Boehm, M.F.5
Fritz, L.C.6
Burrows, F.J.7
-
54
-
-
84855459627
-
The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor
-
Kobayashi N, Toyooka S, Soh J, Yamamoto H, Dote H, Kawasaki K, Otani H, Kubo T, Jida M, Ueno T, Ando M, Ogino A, Kiura K, Miyoshi S. 2012. The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor. Lung Cancer 75:161-166.
-
(2012)
Lung Cancer
, vol.75
, pp. 161-166
-
-
Kobayashi, N.1
Toyooka, S.2
Soh, J.3
Yamamoto, H.4
Dote, H.5
Kawasaki, K.6
Otani, H.7
Kubo, T.8
Jida, M.9
Ueno, T.10
Ando, M.11
Ogino, A.12
Kiura, K.13
Miyoshi, S.14
-
55
-
-
84856934940
-
Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells
-
Tatokoro M, Koga F, Yoshida S, Kawakami S, Fujii Y, Neckers L, Kihara K. 2012. Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int. J. Cancer 131:987-996.
-
(2012)
Int. J. Cancer
, vol.131
, pp. 987-996
-
-
Tatokoro, M.1
Koga, F.2
Yoshida, S.3
Kawakami, S.4
Fujii, Y.5
Neckers, L.6
Kihara, K.7
-
56
-
-
79956017927
-
Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells
-
Li D, Marchenko ND, Schulz R, Fischer V, Velasco-Hernandez T, Talos F, Moll UM. 2011. Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells. Mol. Cancer Res. 9:577-588.
-
(2011)
Mol. Cancer Res.
, vol.9
, pp. 577-588
-
-
Li, D.1
Marchenko, N.D.2
Schulz, R.3
Fischer, V.4
Velasco-Hernandez, T.5
Talos, F.6
Moll, U.M.7
-
57
-
-
77955870224
-
17-DMAG targets the nuclear factorkappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
-
Hertlein E, Wagner AJ, Jones J, Lin TS, Maddocks KJ, Towns WH, III, Goettl VM, Zhang X, Jarjoura D, Raymond CA, West DA, Croce CM, Byrd JC, Johnson AJ. 2010. 17-DMAG targets the nuclear factorkappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition. Blood 116:45-53.
-
(2010)
Blood
, vol.116
, pp. 45-53
-
-
Hertlein, E.1
Wagner, A.J.2
Jones, J.3
Lin, T.S.4
Maddocks, K.J.5
Towns, W.H.6
Goettl, V.M.7
Zhang, X.8
Jarjoura, D.9
Raymond, C.A.10
West, D.A.11
Croce, C.M.12
Byrd, J.C.13
Johnson, A.J.14
-
58
-
-
77649261204
-
Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism
-
Sun X, Barlow EA, Ma S, Hagemeier SR, Duellman SJ, Burgess RR, Tellam J, Khanna R, Kenney SC. 2010. Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 107:3146-3151.
-
(2010)
Proc. Natl. Acad. Sci. U. S. A.
, vol.107
, pp. 3146-3151
-
-
Sun, X.1
Barlow, E.A.2
Ma, S.3
Hagemeier, S.R.4
Duellman, S.J.5
Burgess, R.R.6
Tellam, J.7
Khanna, R.8
Kenney, S.C.9
-
59
-
-
0033918948
-
Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells
-
Molesworth SJ, Lake CM, Borza CM, Turk SM, Hutt-Fletcher LM. 2000. Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J. Virol. 74:6324-6332.
-
(2000)
J. Virol.
, vol.74
, pp. 6324-6332
-
-
Molesworth, S.J.1
Lake, C.M.2
Borza, C.M.3
Turk, S.M.4
Hutt-Fletcher, L.M.5
-
60
-
-
84880360676
-
A conserved gammaherpesvirus protein kinase targets histone deacetylases 1 and 2 to facilitate viral replication in primary macrophages
-
Mounce BC, Mboko WP, Bigley TM, Terhune SS, Tarakanova VL. 2013. A conserved gammaherpesvirus protein kinase targets histone deacetylases 1 and 2 to facilitate viral replication in primary macrophages. J. Virol. 87:7314-7325.
-
(2013)
J. Virol.
, vol.87
, pp. 7314-7325
-
-
Mounce, B.C.1
Mboko, W.P.2
Bigley, T.M.3
Terhune, S.S.4
Tarakanova, V.L.5
-
61
-
-
33750491062
-
Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors
-
Lin D-Y, Huang Y-S, Jeng J-C, Kuo H-Y, Chang C-C, Chao T-T, Ho C-C, Chen Y-C, Lin T-P, Fang H-I, Hung C-C, Suen C-S, Hwang M-J, Chang K-S, Maul GG, Shih H-M. 2006. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24:341-354.
-
(2006)
Mol. Cell
, vol.24
, pp. 341-354
-
-
Lin, D.-Y.1
Huang, Y.-S.2
Jeng, J.-C.3
Kuo, H.-Y.4
Chang, C.-C.5
Chao, T.-T.6
Ho, C.-C.7
Chen, Y.-C.8
Lin, T.-P.9
Fang, H.-I.10
Hung, C.-C.11
Suen, C.-S.12
Hwang, M.-J.13
Chang, K.-S.14
Maul, G.G.15
Shih, H.-M.16
-
62
-
-
0029931715
-
Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: effects on EBV transcription and lytic replication
-
Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S. 1996. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: effects on EBV transcription and lytic replication. J. Virol. 70:5131-5142.
-
(1996)
J. Virol.
, vol.70
, pp. 5131-5142
-
-
Zhang, Q.1
Hong, Y.2
Dorsky, D.3
Holley-Guthrie, E.4
Zalani, S.5
Elshiekh, N.A.6
Kiehl, A.7
Le, T.8
Kenney, S.9
-
63
-
-
33846014703
-
An acetylation site in the middle domain of Hsp90 regulates chaperone function
-
Scroggins BT, Robzyk K, Wang D, Marcu MG, Tsutsumi S, Beebe K, Cotter RJ, Felts S, Toft D, Karnitz L, Rosen N, Neckers L. 2007. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol. Cell 25:151-159.
-
(2007)
Mol. Cell
, vol.25
, pp. 151-159
-
-
Scroggins, B.T.1
Robzyk, K.2
Wang, D.3
Marcu, M.G.4
Tsutsumi, S.5
Beebe, K.6
Cotter, R.J.7
Felts, S.8
Toft, D.9
Karnitz, L.10
Rosen, N.11
Neckers, L.12
-
64
-
-
28044472990
-
Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles
-
Wang J-T, Yang P-W, Lee C-P, Han C-H, Tsai C-H, Chen M-R. 2005. Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J. Gen. Virol. 86:3215-3225.
-
(2005)
J. Gen. Virol.
, vol.86
, pp. 3215-3225
-
-
Wang, J.-T.1
Yang, P.-W.2
Lee, C.-P.3
Han, C.-H.4
Tsai, C.-H.5
Chen, M.-R.6
-
65
-
-
0028801332
-
Human cytomegalovirus IE1 and IE2 proteins block apoptosis
-
Zhu H, Shen Y, Shenk T. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:7960-7970.
-
(1995)
J. Virol.
, vol.69
, pp. 7960-7970
-
-
Zhu, H.1
Shen, Y.2
Shenk, T.3
-
66
-
-
0031060542
-
The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines
-
He Z, He YS, Kim Y, Chu L, Ohmstede C, Biron KK, Coen DM. 1997. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J. Virol. 71:405-411.
-
(1997)
J. Virol.
, vol.71
, pp. 405-411
-
-
He, Z.1
He, Y.S.2
Kim, Y.3
Chu, L.4
Ohmstede, C.5
Biron, K.K.6
Coen, D.M.7
-
67
-
-
34249947228
-
Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles
-
Gill MB, Kutok JL, Fingeroth JD. 2007. Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles. J. Virol. 81:6523-6535.
-
(2007)
J. Virol.
, vol.81
, pp. 6523-6535
-
-
Gill, M.B.1
Kutok, J.L.2
Fingeroth, J.D.3
-
68
-
-
0031724984
-
The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase
-
Gustafson EA, Chillemi AC, Sage DR, Fingeroth JD. 1998. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase. Antimicrob. Agents Chemother. 42:2923-2931.
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 2923-2931
-
-
Gustafson, E.A.1
Chillemi, A.C.2
Sage, D.R.3
Fingeroth, J.D.4
-
69
-
-
0033986103
-
Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir
-
Gustafson EA, Schinazi RF, Fingeroth JD. 2000. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir. J. Virol. 74:684-692.
-
(2000)
J. Virol.
, vol.74
, pp. 684-692
-
-
Gustafson, E.A.1
Schinazi, R.F.2
Fingeroth, J.D.3
-
70
-
-
0034660443
-
The Epstein-Barr virus lytic program is controlled by the cooperative functions of two transactivators
-
Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W, Delecluse H-J. 2000. The Epstein-Barr virus lytic program is controlled by the cooperative functions of two transactivators. EMBO J. 19:3080-3089.
-
(2000)
EMBO J.
, vol.19
, pp. 3080-3089
-
-
Feederle, R.1
Kost, M.2
Baumann, M.3
Janz, A.4
Drouet, E.5
Hammerschmidt, W.6
Delecluse, H.-J.7
-
71
-
-
0022895276
-
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
-
Raab-Traub N, Flynn K. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47: 883-889.
-
(1986)
Cell
, vol.47
, pp. 883-889
-
-
Raab-Traub, N.1
Flynn, K.2
-
72
-
-
77953077420
-
A global protein kinase and phosphatase interaction network in yeast
-
Breitkreutz A, Choi H, Sharom JR, Boucher L, Neduva V, Larsen B, Lin Z-Y, Breitkreutz B-J, Stark C, Liu G, Ahn J, Dewar-Darch D, Reguly T, Tang X, Almeida R, Qin ZS, Pawson T, Gingras A-C, Nesvizhskii AI, Tyers M. 2010. A global protein kinase and phosphatase interaction network in yeast. Science 328:1043-1046.
-
(2010)
Science
, vol.328
, pp. 1043-1046
-
-
Breitkreutz, A.1
Choi, H.2
Sharom, J.R.3
Boucher, L.4
Neduva, V.5
Larsen, B.6
Lin, Z.-Y.7
Breitkreutz, B.-J.8
Stark, C.9
Liu, G.10
Ahn, J.11
Dewar-Darch, D.12
Reguly, T.13
Tang, X.14
Almeida, R.15
Qin, Z.S.16
Pawson, T.17
Gingras, A.-C.18
Nesvizhskii, A.I.19
Tyers, M.20
more..
-
73
-
-
12344291243
-
Hsp90 and Cdc37-a chaperone cancer conspiracy
-
Pearl LH. 2005. Hsp90 and Cdc37-a chaperone cancer conspiracy. Curr. Opin. Genet. Dev. 15:55-61.
-
(2005)
Curr. Opin. Genet. Dev.
, vol.15
, pp. 55-61
-
-
Pearl, L.H.1
-
74
-
-
36048975114
-
Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G(2)/M arrest in glioblastoma cell lines
-
García-Morales P, Carrasco-García E, Ruiz-Rico P, Martínez-Mira R, Menéndez-Gutiérrez MP, Ferragut JA, Saceda M, Martínez-Lacaci I. 2007. Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G(2)/M arrest in glioblastoma cell lines. Oncogene 26:7185-7193.
-
(2007)
Oncogene
, vol.26
, pp. 7185-7193
-
-
García-Morales, P.1
Carrasco-García, E.2
Ruiz-Rico, P.3
Martínez-Mira, R.4
Menéndez-Gutiérrez, MP.5
Ferragut, J.A.6
Saceda, M.7
Martínez-Lacaci, I.8
-
75
-
-
34047149824
-
Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1
-
Nomura N, Nomura M, Newcomb EW, Zagzag D. 2007. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1. Biochem. Pharmacol. 73:1528-1536.
-
(2007)
Biochem. Pharmacol.
, vol.73
, pp. 1528-1536
-
-
Nomura, N.1
Nomura, M.2
Newcomb, E.W.3
Zagzag, D.4
-
76
-
-
0034099654
-
Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway
-
Fahmi H, Cochet C, Hmama Z, Opolon P, Joab I. 2000. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway. J. Virol. 74:5810-5818.
-
(2000)
J. Virol.
, vol.74
, pp. 5810-5818
-
-
Fahmi, H.1
Cochet, C.2
Hmama, Z.3
Opolon, P.4
Joab, I.5
-
77
-
-
84866870218
-
Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells
-
Kang S-A, Cho H-S, Yoon JB, Chung IK, Lee S-T. 2012. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells. Biochem. J. 447:313-320.
-
(2012)
Biochem. J.
, vol.447
, pp. 313-320
-
-
Kang, S.-A.1
Cho, H.-S.2
Yoon, J.B.3
Chung, I.K.4
Lee, S.-T.5
-
78
-
-
78649954012
-
Mineralocorticoid receptor degradation is promoted by Hsp90 inhibition and the ubiquitin-protein ligase CHIP
-
doi:10.1152/ajprenal.00285.2010.
-
Faresse N, Ruffieux-Daidie D, Salamin M, Gomez-Sanchez CE, Staub O. 2010. Mineralocorticoid receptor degradation is promoted by Hsp90 inhibition and the ubiquitin-protein ligase CHIP. Am. J. Physiol. Renal Physiol. 299:F1462-F1472. doi:10.1152/ajprenal.00285.2010.
-
(2010)
Am. J. Physiol. Renal Physiol.
, vol.299
-
-
Faresse, N.1
Ruffieux-Daidie, D.2
Salamin, M.3
Gomez-Sanchez, C.E.4
Staub, O.5
-
79
-
-
84868553748
-
Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-β type II receptor
-
Noh H, Kim HJ, Yu MR, Kim W-Y, Kim J, Ryu JH, Kwon SH, Jeon JS, Han DC, Ziyadeh F. 2012. Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-β type II receptor. Lab. Invest. 92:1583-1596.
-
(2012)
Lab. Invest.
, vol.92
, pp. 1583-1596
-
-
Noh, H.1
Kim, H.J.2
Yu, M.R.3
Kim, W.-Y.4
Kim, J.5
Ryu, J.H.6
Kwon, S.H.7
Jeon, J.S.8
Han, D.C.9
Ziyadeh, F.10
-
80
-
-
34250886966
-
Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation
-
Qing G, Yan P, Qu Z, Liu H, Xiao G. 2007. Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation. Cell Res. 17:520-530.
-
(2007)
Cell Res.
, vol.17
, pp. 520-530
-
-
Qing, G.1
Yan, P.2
Qu, Z.3
Liu, H.4
Xiao, G.5
-
81
-
-
66149128366
-
Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy
-
Shen S, Zhang P, Lovchik MA, Li Y, Tang L, Chen Z, Zeng R, Ma D, Yuan J, Yu Q. 2009. Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy. J. Cell Biol. 185:629-639.
-
(2009)
J. Cell Biol.
, vol.185
, pp. 629-639
-
-
Shen, S.1
Zhang, P.2
Lovchik, M.A.3
Li, Y.4
Tang, L.5
Chen, Z.6
Zeng, R.7
Ma, D.8
Yuan, J.9
Yu, Q.10
-
82
-
-
84858152476
-
SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells
-
Liu K-S, Liu H, Qi J-H, Liu Q-Y, Liu Z, Xia M, Xing G-W, Wang S-X, Wang Y-F. 2012. SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells. Cancer Lett. 318:180-188.
-
(2012)
Cancer Lett.
, vol.318
, pp. 180-188
-
-
Liu, K.-S.1
Liu, H.2
Qi, J.-H.3
Liu, Q.-Y.4
Liu, Z.5
Xia, M.6
Xing, G.-W.7
Wang, S.-X.8
Wang, Y.-F.9
-
83
-
-
84863792269
-
Cdc37/Hsp90 protein complex disruption triggers an autophagic clearance cascade for TDP-43 protein
-
Jinwal UK, Abisambra JF, Zhang J, Dharia S, O'Leary JC, Patel T, Braswell K, Jani T, Gestwicki JE, Dickey CA. 2012. Cdc37/Hsp90 protein complex disruption triggers an autophagic clearance cascade for TDP-43 protein. J. Biol. Chem. 287:24814-24820.
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 24814-24820
-
-
Jinwal, U.K.1
Abisambra, J.F.2
Zhang, J.3
Dharia, S.4
O'Leary, J.C.5
Patel, T.6
Braswell, K.7
Jani, T.8
Gestwicki, J.E.9
Dickey, C.A.10
-
84
-
-
84871575241
-
Nucleoside and nucleotide analogues for the treatment of herpesvirus infections: current stage and new prospects in the field of acyclic nucleoside phosphonates
-
In-Tech, New York, NY. doi:10.5772/27995.
-
Krecmerova M. 2012. Nucleoside and nucleotide analogues for the treatment of herpesvirus infections: current stage and new prospects in the field of acyclic nucleoside phosphonates, p 245-270. In Magel GD (ed), Herpesviridae-a look into this unique family of viruses. In-Tech, New York, NY. doi:10.5772/27995.
-
(2012)
In Magel GD (ed), Herpesviridae-a look into this unique family of viruses
, pp. 245-270
-
-
Krecmerova, M.1
-
85
-
-
67349265475
-
Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase
-
Murata T, Isomura H, Yamashita Y, Toyama S, Sato Y, Nakayama S, Kudoh A, Iwahori S, Kanda T, Tsurumi T. 2009. Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase. Virology 389:75-81.
-
(2009)
Virology
, vol.389
, pp. 75-81
-
-
Murata, T.1
Isomura, H.2
Yamashita, Y.3
Toyama, S.4
Sato, Y.5
Nakayama, S.6
Kudoh, A.7
Iwahori, S.8
Kanda, T.9
Tsurumi, T.10
-
86
-
-
70349730029
-
Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase
-
Kamil JP, Hume AJ, Jurak I, Münger K, Kalejta RF, Coen DM. 2009. Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. Proc. Natl. Acad. Sci. U. S. A. 106:16823-16828.
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, pp. 16823-16828
-
-
Kamil, J.P.1
Hume, A.J.2
Jurak, I.3
Münger, K.4
Kalejta, R.F.5
Coen, D.M.6
-
87
-
-
0036842742
-
Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents
-
Neckers L, Neckers K. 2002. Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents. Expert Opin. Emerg. Drugs 7:277-288.
-
(2002)
Expert Opin. Emerg. Drugs
, vol.7
, pp. 277-288
-
-
Neckers, L.1
Neckers, K.2
-
88
-
-
0027433644
-
Raf exists in a native heterocomplex with hsp90 and p50 that can be reconstituted in a cell-free system
-
Stancato LF, Chow YH, Hutchison KA, Perdew GH, Jove R, Pratt WB. 1993. Raf exists in a native heterocomplex with hsp90 and p50 that can be reconstituted in a cell-free system. J. Biol. Chem. 268:21711-21716.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 21711-21716
-
-
Stancato, L.F.1
Chow, Y.H.2
Hutchison, K.A.3
Perdew, G.H.4
Jove, R.5
Pratt, W.B.6
-
89
-
-
0029838168
-
Physical interaction of mammalian CDC37 with CDK4
-
Dai K, Kobayashi R, Beach D. 1996. Physical interaction of mammalian CDC37 with CDK4. J. Biol. Chem. 271:22030-22034.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 22030-22034
-
-
Dai, K.1
Kobayashi, R.2
Beach, D.3
-
90
-
-
0742269688
-
The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37)
-
Roe SM, Ali MMU, Meyer P, Vaughan CK, Panaretou B, Piper PW, Prodromou C, Pearl LH. 2004. The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37). Cell 116:87-98.
-
(2004)
Cell
, vol.116
, pp. 87-98
-
-
Roe, S.M.1
Ali, M.M.U.2
Meyer, P.3
Vaughan, C.K.4
Panaretou, B.5
Piper, P.W.6
Prodromou, C.7
Pearl, L.H.8
-
91
-
-
33751111683
-
Hsp90 inhibition results in autophagymediated proteasome-independent degradation of IkappaB kinase (IKK)
-
Qing G, Yan P, Xiao G. 2006. Hsp90 inhibition results in autophagymediated proteasome-independent degradation of IkappaB kinase (IKK). Cell Res. 16:895-901.
-
(2006)
Cell Res.
, vol.16
, pp. 895-901
-
-
Qing, G.1
Yan, P.2
Xiao, G.3
-
92
-
-
34547745387
-
A functional heat shock protein 90 chaperone is essential for efficient flock house virus RNA polymerase synthesis in Drosophila cells
-
Castorena KM, Weeks SA, Stapleford KA, Cadwallader AM, Miller DJ. 2007. A functional heat shock protein 90 chaperone is essential for efficient flock house virus RNA polymerase synthesis in Drosophila cells. J. Virol. 81:8412-8420.
-
(2007)
J. Virol.
, vol.81
, pp. 8412-8420
-
-
Castorena, K.M.1
Weeks, S.A.2
Stapleford, K.A.3
Cadwallader, A.M.4
Miller, D.J.5
-
93
-
-
23244444185
-
Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus
-
Burch AD, Weller SK. 2005. Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus. J. Virol. 79:10740-10749.
-
(2005)
J. Virol.
, vol.79
, pp. 10740-10749
-
-
Burch, A.D.1
Weller, S.K.2
-
94
-
-
84878180356
-
Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90
-
Kawashima D, Kanda T, Murata T, Saito S, Sugimoto A, Narita Y, Tsurumi T. 2013. Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90. J. Virol. 87:6482-6491.
-
(2013)
J. Virol.
, vol.87
, pp. 6482-6491
-
-
Kawashima, D.1
Kanda, T.2
Murata, T.3
Saito, S.4
Sugimoto, A.5
Narita, Y.6
Tsurumi, T.7
-
95
-
-
23244468118
-
Geldanamycin, a potent and specific inhibitor of Hsp90, inhibits gene expression and replication of human cytomegalovirus
-
Basha W, Kitagawa R, Uhara M, Imazu H, Uechi K, Tanaka J. 2005. Geldanamycin, a potent and specific inhibitor of Hsp90, inhibits gene expression and replication of human cytomegalovirus. Antivir. Chem. Chemother. 16:135-146.
-
(2005)
Antivir. Chem. Chemother.
, vol.16
, pp. 135-146
-
-
Basha, W.1
Kitagawa, R.2
Uhara, M.3
Imazu, H.4
Uechi, K.5
Tanaka, J.6
-
96
-
-
77953285870
-
Extracellular Hsp90 serves as a cofactor forMAPKactivation and latent viral gene expression during de novo infection by KSHV
-
Qin Z, DeFee M, Isaacs JS, Parsons C. 2010. Extracellular Hsp90 serves as a cofactor forMAPKactivation and latent viral gene expression during de novo infection by KSHV. Virology 403:92-102.
-
(2010)
Virology
, vol.403
, pp. 92-102
-
-
Qin, Z.1
DeFee, M.2
Isaacs, J.S.3
Parsons, C.4
-
97
-
-
84870792928
-
Hsp90 inhibitors are efficacious against Kaposi sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins
-
doi:10.1371 /journal.ppat.1003048.
-
Chen W, Sin S-H, Wen KW, Damania B, Dittmer DP. 2012. Hsp90 inhibitors are efficacious against Kaposi sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins. PLoS Pathog. 8:e1003048. doi:10.1371 /journal.ppat.1003048.
-
(2012)
PLoS Pathog.
, vol.8
-
-
Chen, W.1
Sin, S.-H.2
Wen, K.W.3
Damania, B.4
Dittmer, D.P.5
-
98
-
-
77953784609
-
Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1
-
Wen KW, Damania B. 2010. Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1. Oncogene 29: 3532-3544.
-
(2010)
Oncogene
, vol.29
, pp. 3532-3544
-
-
Wen, K.W.1
Damania, B.2
-
99
-
-
84877022289
-
Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma
-
doi:10.1371/journal.pone.0063566.
-
Murata T, Iwata S, Siddiquey MNA, Kanazawa T, Goshima F, Kawashima D, Kimura H, Tsurumi T. 2013. Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma. PLoS One 8:e63566. doi:10.1371/journal.pone.0063566.
-
(2013)
PLoS One
, vol.8
-
-
Murata, T.1
Iwata, S.2
Siddiquey, M.N.A.3
Kanazawa, T.4
Goshima, F.5
Kawashima, D.6
Kimura, H.7
Tsurumi, T.8
-
100
-
-
84865839031
-
HSP90 inhibitors for cancer therapy and overcoming drug resistance
-
Jhaveri K, Modi S. 2012. HSP90 inhibitors for cancer therapy and overcoming drug resistance. Adv. Pharmacol. 65:471-517.
-
(2012)
Adv. Pharmacol.
, vol.65
, pp. 471-517
-
-
Jhaveri, K.1
Modi, S.2
-
101
-
-
4344674482
-
Targeting multiple signal transduction pathways through inhibition of Hsp90
-
Zhang H, Burrows F. 2004. Targeting multiple signal transduction pathways through inhibition of Hsp90. J. Mol. Med. 82:488-499.
-
(2004)
J. Mol. Med.
, vol.82
, pp. 488-499
-
-
Zhang, H.1
Burrows, F.2
-
102
-
-
28144439948
-
HSP90: a rising star on the horizon of anticancer targets
-
Dai C, Whitesell L. 2005. HSP90: a rising star on the horizon of anticancer targets. Future Oncol. 1:529-540.
-
(2005)
Future Oncol.
, vol.1
, pp. 529-540
-
-
Dai, C.1
Whitesell, L.2
-
103
-
-
79955432735
-
Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment
-
Patel HJ, Modi S, Chiosis G, Taldone T. 2011. Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment. Expert Opin. Drug Discov. 6:559-587.
-
(2011)
Expert Opin. Drug Discov.
, vol.6
, pp. 559-587
-
-
Patel, H.J.1
Modi, S.2
Chiosis, G.3
Taldone, T.4
|